Lista de obras - Francisco Carrillo-Salinas

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.

artículo científico publicado en 2018

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

artículo científico publicado en 2017

2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions

scientific article published on 02 January 2020

A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis

artículo científico publicado en 2015

A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis

artículo científico publicado en 2014

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

artículo científico publicado en 2012

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

artículo científico publicado en 2014

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

artículo científico publicado en 2013

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis

artículo científico publicado en 2016

Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

artículo científico publicado en 2016

Endocannabinoids drive the acquisition of an alternative phenotype in microglia

artículo científico publicado en 2015

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

scientific article published on 14 March 2017

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner

artículo científico publicado en 2020

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

scientific article published on 30 August 2018

Heart Inflammation: Immune Cell Roles and Roads to the Heart

artículo científico publicado en 2019

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

artículo científico publicado en 2020

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

artículo científico publicado en 2018

Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.

artículo científico publicado en 2018

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

artículo científico publicado en 2019

Microglia activation states and cannabinoid system: Therapeutic implications.

artículo científico publicado en 2016

Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites

artículo científico publicado en 2013

PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

artículo científico publicado en 2015

Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation

scientific article published on 26 August 2019

Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration

scientific article published on 17 February 2019

T-cell recruitment to the heart: friendly guests or unwelcome visitors?

scientific article published on 10 May 2019

Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

artículo científico publicado en 2017

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors

artículo científico publicado en 2015

The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia

artículo científico publicado en 2018

Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis

scientific article published in PLoS ONE

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.

artículo científico publicado en 2012

Lista de obras de Francisco Carrillo-Salinas

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions

A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis

A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis

Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Endocannabinoids drive the acquisition of an alternative phenotype in microglia

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

Heart Inflammation: Immune Cell Roles and Roads to the Heart

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Microglia activation states and cannabinoid system: Therapeutic implications.

Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites

PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation

Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration

T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors

The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia

Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.